Debanjana Chatterjee
Stock Analyst at JonesTrading
(4.94)
# 149
Out of 4,996 analysts
260
Total ratings
63.1%
Success rate
41.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Debanjana Chatterjee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CTNM Contineum Therapeutics | Maintained: Buy | $24 | $13.53 | +77.38% | 14 | Sep 21, 2026 | |
| HYFT MindWalk Holdings | Reiterated: Buy | $5 | $1.36 | +267.65% | 3 | Sep 15, 2026 | |
| TVRD Tvardi Therapeutics | Reiterated: Buy | $12 → $10 | $1.63 | +513.50% | 18 | Sep 15, 2026 | |
| IRD Opus Genetics | Reiterated: Buy | $10 | $5.18 | +93.05% | 24 | Sep 9, 2026 | |
| PHVS Pharvaris | Reiterated: Buy | $52 → $65 | $36.37 | +78.72% | 15 | Sep 9, 2026 | |
| ARMP Armata Pharmaceuticals | Reiterated: Buy | $20 | $4.18 | +378.47% | 6 | Aug 28, 2026 | |
| ATHE Alterity Therapeutics | Reiterated: Buy | $16 | $3.91 | +309.21% | 4 | Aug 28, 2026 | |
| SYRE Spyre Therapeutics | Reiterated: Buy | $140 → $121 | $90.25 | +34.07% | 20 | Aug 26, 2026 | |
| SGMT Sagimet Biosciences | Reiterated: Buy | $31 | $11.09 | +179.53% | 18 | Aug 25, 2026 | |
| EVAX Evaxion | Reiterated: Buy | $10 | $3.27 | +205.81% | 4 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $43 → $20 | $3.85 | +419.48% | 28 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $12.14 | +138.88% | 28 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $24 → $28 | $14.95 | +87.29% | 22 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $9.65 | +34.72% | 19 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $25 | $12.63 | +97.94% | 8 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $63 | $5.96 | +957.05% | 9 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $19 → $17 | $17.02 | -0.12% | 12 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0232 | - | 8 | May 22, 2026 |
Contineum Therapeutics
Sep 21, 2026
Maintained: Buy
Price Target: $24
Current: $13.53
Upside: +77.38%
MindWalk Holdings
Sep 15, 2026
Reiterated: Buy
Price Target: $5
Current: $1.36
Upside: +267.65%
Tvardi Therapeutics
Sep 15, 2026
Reiterated: Buy
Price Target: $12 → $10
Current: $1.63
Upside: +513.50%
Opus Genetics
Sep 9, 2026
Reiterated: Buy
Price Target: $10
Current: $5.18
Upside: +93.05%
Pharvaris
Sep 9, 2026
Reiterated: Buy
Price Target: $52 → $65
Current: $36.37
Upside: +78.72%
Armata Pharmaceuticals
Aug 28, 2026
Reiterated: Buy
Price Target: $20
Current: $4.18
Upside: +378.47%
Alterity Therapeutics
Aug 28, 2026
Reiterated: Buy
Price Target: $16
Current: $3.91
Upside: +309.21%
Spyre Therapeutics
Aug 26, 2026
Reiterated: Buy
Price Target: $140 → $121
Current: $90.25
Upside: +34.07%
Sagimet Biosciences
Aug 25, 2026
Reiterated: Buy
Price Target: $31
Current: $11.09
Upside: +179.53%
Evaxion
Aug 21, 2026
Reiterated: Buy
Price Target: $10
Current: $3.27
Upside: +205.81%
Aug 18, 2026
Reiterated: Buy
Price Target: $43 → $20
Current: $3.85
Upside: +419.48%
Aug 14, 2026
Reiterated: Buy
Price Target: $29
Current: $12.14
Upside: +138.88%
Aug 13, 2026
Rated: Buy
Price Target: $24 → $28
Current: $14.95
Upside: +87.29%
Aug 12, 2026
Reiterated: Buy
Price Target: $13
Current: $9.65
Upside: +34.72%
Aug 10, 2026
Reiterated: Buy
Price Target: $13 → $25
Current: $12.63
Upside: +97.94%
Aug 10, 2026
Downgraded: Hold
Price Target: $63
Current: $5.96
Upside: +957.05%
Jun 29, 2026
Downgraded: Hold
Price Target: $19 → $17
Current: $17.02
Upside: -0.12%
May 22, 2026
Rated: Hold
Price Target: n/a
Current: $0.0232
Upside: -